CTI BioPharma Corp.

Updates from The Motley Fool

Latest updates on CTI BioPharma from Fool.com.  The Fool has written over 100 articles on CTI BioPharma.
3 Stocks to Get on Your Watchlist

A big-box retail giant, an up-and-coming developer of a tardive dyskinesia treatment, and a short...

This Week in Biotech

Four big rulings from the likes of the FDA, EMA, and USPTO, as well as one impressive clinical tr...

Stock Performance

View Interactive CTIC Charts
Sponsored by

Key Data Points

Primary metrics and data points about CTI BioPharma.
Current Price: $3.31
Prev Close: $3.29
Open: $3.28
Bid: $3.29
Ask: $3.31
Day's Range: $3.28 - $3.33
52wk Range: $2.70 - $6.48
Volume: 12,861
Avg Vol 139,002
Market Cap: $496M
P/E (ttm): -1.73
EPS (ttm): ($1.90)
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

James A. Bianco, CEO

42% Approve

Based on 6 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for CTI BioPharma.

CTI BioPharma Corp.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers